View in EDS

1437PPhase I dose expansion data for M6620 (formerly VX-970), a first-in-class ATR inhibitor, combined with gemcitabine (Gem) in patients (pts) with advanced non-small cell lung cancer (NSCLC).

Saved in:
Bibliographic Details
Title: 1437PPhase I dose expansion data for M6620 (formerly VX-970), a first-in-class ATR inhibitor, combined with gemcitabine (Gem) in patients (pts) with advanced non-small cell lung cancer (NSCLC).
Authors: Plummer, R1 (AUTHOR), Cook, N2 (AUTHOR), Arkenau, T3 (AUTHOR), Melear, J4 (AUTHOR), Redfern, C5 (AUTHOR), Spira, A I6 (AUTHOR), Chung, K7 (AUTHOR), Haddad, T8 (AUTHOR), Ramalingam, S S9 (AUTHOR), Wesolowski, R10 (AUTHOR)
Source: Annals of Oncology. 2018 Supplement, Vol. 29, pN.PAG-N.PAG. 1p.
Database: Academic Search Ultimate
Description
ISSN:09237534
DOI:10.1093/annonc/mdy292.059